{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:23Z","timestamp":1790096903907,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drudis.2026.104766","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:16:36Z","timestamp":1786547796000},"page":"104766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From structural biology to precision medicine\u2014decoding the key receptor in thyroid disorders"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4971-009X","authenticated-orcid":false,"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104766_b0005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/cells12060918","article-title":"Molecular mechanisms in autoimmune thyroid disease","volume":"12","author":"Vargas-Uricoechea","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104766_b0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104766_b0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41467-017-00357-2","article-title":"Internalized TSH receptors en route to the TGN induce local G(s)-protein signaling and gene transcription","volume":"8","author":"Godbole","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104766_b0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/JME-12-0200","article-title":"TSH induces metallothionein 1 in thyrocytes via Gq\/11- and PKC-dependent signaling","volume":"51","author":"B\u00e4ck","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.drudis.2026.104766_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1062045","article-title":"A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy","volume":"14","author":"Cui","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104766_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4158\/EP-2019-0363","article-title":"TSH receptor antibodies: relevance & utility","volume":"26","author":"Kahaly","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.drudis.2026.104766_b0035","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41586-022-05173-3","article-title":"Hormone- and antibody-mediated activation of the thyrotropin receptor","volume":"609","author":"Duan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104766_b0040","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.ejhg.5201485","article-title":"Association of the TSHR gene with Graves\u2019 disease: the first disease specific locus","volume":"13","author":"Dechairo","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.drudis.2026.104766_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107502","article-title":"TSH\/IGF1 receptor crosstalk: mechanism and clinical implications","volume":"209","author":"Krieger","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104766_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of the TSHR","volume":"322","author":"Brand","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"105","key":"10.1016\/j.drudis.2026.104766_b0055","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1210\/clinem\/dgz292","article-title":"Prospective trial of functional thyrotropin receptor antibodies in Graves\u2019 disease","volume":"2020","author":"Kahaly","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.drudis.2026.104766_b0060","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/0006-291X(89)92736-8","article-title":"Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies","volume":"165","author":"Libert","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2026.104766_b0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.2010.1638","article-title":"The genetics of the thyroid stimulating hormone receptor: history and relevance","volume":"20","author":"Davies","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/thy.1994.4.255","article-title":"Sequence analysis of the thyrotropin (TSH) receptor gene in congenital primary hypothyroidism associated with TSH unresponsiveness","volume":"4","author":"Takeshita","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/thy.2000.10.1051","article-title":"Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies","volume":"10","author":"Oda","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0080","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/thy.2007.0239","article-title":"TSH receptor antibodies","volume":"17","author":"Smith","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0085","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1210\/en.2008-1800","article-title":"A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain","volume":"150","author":"Chen","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0090","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1515\/CCLM.2009.245","article-title":"First automated assay for thyrotropin receptor autoantibodies","volume":"47","author":"Gassner","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.drudis.2026.104766_b0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1055\/s-0042-121012","article-title":"Clinical evaluation of the first automated assay for the detection of stimulating TSH receptor autoantibodies","volume":"48","author":"Allelein","year":"2016","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.drudis.2026.104766_b0100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-021-03924-2","article-title":"Structures of full-length glycoprotein hormone receptor signalling complexes","volume":"598","author":"Duan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104766_b0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0035-1559648","article-title":"Mechanisms of action of TSHR autoantibodies","volume":"47","author":"Furmaniak","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.drudis.2026.104766_b0110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41586-022-05159-1","article-title":"Autoantibody mimicry of hormone action at the thyrotropin receptor","volume":"609","author":"Faust","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104766_b0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.drudis.2026.104766_b0120","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1210\/en.2011-1389","article-title":"The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH","volume":"152","author":"Jaeschke","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040291","article-title":"The hinge region of human thyroid-stimulating hormone (TSH) receptor operates as a tunable switch between hormone binding and receptor activation","volume":"7","author":"Majumdar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104766_b0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tem.2009.09.001","article-title":"The hinge region: an important receptor component for GPHR function","volume":"21","author":"Mueller","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.drudis.2026.104766_b0145","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1210\/en.2009-1430","article-title":"Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation","volume":"151","author":"Chen","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0150","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1210\/en.2011-0153","article-title":"Identification of novel TSH interaction sites by systematic binding analysis of the TSHR hinge region","volume":"152","author":"Mueller","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0155","doi-asserted-by":"crossref","first-page":"18048","DOI":"10.1074\/jbc.M800449200","article-title":"Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation","volume":"283","author":"Mueller","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0160","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1074\/jbc.M110.211003","article-title":"Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142250","article-title":"Molecular insights into the transmembrane domain of the thyrotropin receptor","volume":"10","author":"Chantreau","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104766_b0170","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.drudis.2020.12.001","article-title":"Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery","volume":"26","author":"Wang","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104766_b0175","article-title":"Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104766_b0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/JME-16-0169","article-title":"Glycosylation pattern analysis of glycoprotein hormones and their receptors","volume":"58","author":"N\u00fa\u00f1ez Miguel","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.drudis.2026.104766_b0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5603\/EP.a2018.0077","article-title":"Glycosylation of thyroid-stimulating hormone receptor","volume":"70","author":"Korta","year":"2019","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.drudis.2026.104766_b0190","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global view of human protein glycosylation pathways and functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104766_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841710","article-title":"Changes of IgG N-glycosylation in thyroid autoimmunity: the modulatory effect of methimazole in Graves\u2019 disease and the association with the severity of inflammation in Hashimoto\u2019s thyroiditis","volume":"13","author":"Trzos","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104766_b0200","first-page":"3582","article-title":"Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma","volume":"20","author":"Liu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.drudis.2026.104766_b0205","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0369","article-title":"TSHR in thyroid cancer: bridging biological insights to targeted strategies","volume":"14","author":"Xu","year":"2025","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.drudis.2026.104766_b0220","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.3390\/ijms20225564","article-title":"The pathogenic TSH \u03b2-subunit variant C105Vfs114X causes a modified signaling profile at TSHR","volume":"20","author":"Kalveram","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104766_b0225","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201800211R","article-title":"Partial thyrocyte-specific G\u03b1(s) deficiency leads to rapid-onset hypothyroidism, hyperplasia, and papillary thyroid carcinoma-like lesions in mice","author":"Patyra","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2026.104766_b0230","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"Beta-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.drudis.2026.104766_b0235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fendo.2020.00312","article-title":"\u03b2-Arrestin 1 in thyrotropin receptor signaling in bone: studies in osteoblast-like cells","volume":"11","author":"Boutin","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"10.1016\/j.drudis.2026.104766_b0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000511871","article-title":"Modulating TSH receptor signaling for therapeutic benefit","volume":"9","author":"Krause","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.drudis.2026.104766_b0245","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/en.2019-00055","article-title":"Arrestin-\u03b2-1 physically scaffolds TSH and IGF1 receptors to enable crosstalk","volume":"160","author":"Krieger","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0250","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.drudis.2026.104766_b0255","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1096\/fj.14-251124","article-title":"\u03b2-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation","volume":"28","author":"Boutin","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2026.104766_b0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.117.244095","article-title":"Discovery of a positive allosteric modulator of the thyrotropin receptor: potentiation of thyrotropin-mediated preosteoblast differentiation in vitro","volume":"364","author":"Neumann","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2026.104766_b0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2017.1288215","article-title":"TSHR as a therapeutic target in Graves' disease","volume":"21","author":"Smith","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.drudis.2026.104766_b0270","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1007\/s00018-019-03274-3","article-title":"G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub","volume":"76","author":"Penela","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2026.104766_b0275","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1055\/a-0749-6528","article-title":"Intervention strategies into glycoprotein hormone receptors for modulating (mal-)function, with special emphasis on the TSH receptor","volume":"50","author":"Krause","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.drudis.2026.104766_b0280","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1515\/CCLM.2009.245","article-title":"First automated assay for thyrotropin receptor autoantibodies","volume":"47","author":"Gassner","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.drudis.2026.104766_b0285","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5937\/jomb0-55873","article-title":"Evaluation of the analytical and clinical characteristics of the siemens immulite\u00ae2000 tsi method for determining thyrotropin receptor antibodies","volume":"44","author":"Milinkovi\u0107","year":"2025","journal-title":"J Med Biochem"},{"key":"10.1016\/j.drudis.2026.104766_b0290","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/thy.2021.0299","article-title":"Diagnostic utility of a new assay for thyroid stimulating immunoglobulins in Graves\u2019 disease and thyroid eye disease","volume":"32","author":"Stan","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2024.113655","article-title":"Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor","volume":"528","author":"Hoshina","year":"2024","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.drudis.2026.104766_b0300","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.molpharmaceut.5c00325","article-title":"Preclinical ImmunoPET imaging of thyroid-stimulating hormone receptor expression in thyroid cancer using [64Cu]Cu-NOTA-TSHR-Ab","volume":"22","author":"Fu","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2026.104766_b0305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.surg.2023.05.045","article-title":"Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer","volume":"175","author":"Gimblet","year":"2024","journal-title":"Surgery"},{"key":"10.1016\/j.drudis.2026.104766_b0315","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1507\/endocrj.EJ22-0391","article-title":"Thyrotropin receptor antagonists and inverse agonists, and their potential application to thyroid diseases","volume":"69","author":"Nagayama","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.drudis.2026.104766_b0320","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/en.2013-1835","article-title":"A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice","volume":"155","author":"Neumann","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0325","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cen.14681","article-title":"TSH receptor specific monoclonal autoantibody K1-70TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy\u2014results from a phase I clinical trial","volume":"96","author":"Furmaniak","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.drudis.2026.104766_b0330","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0120","article-title":"Structure of full-length TSH receptor in complex with antibody K1-70\u2122","volume":"70","author":"N\u00fa\u00f1ez Miguel","year":"2023","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.drudis.2026.104766_b0335","article-title":"Targeted immunotherapies for Graves\u2019 thyroidal & orbital diseases","volume":"16","author":"Lee","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104766_b0340","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/thy.2005.15.672","article-title":"Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist","volume":"15","author":"Sanders","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0345","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/thy.2007.0327","article-title":"A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity","volume":"18","author":"Sanders","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0350","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/thy.2018.0176","article-title":"Structure of a thyrotropin receptor monoclonal antibody variable region provides insight into potential mechanisms for its inverse agonist activity","volume":"28","author":"Chen","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0355","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/105072502321085135","article-title":"Thyroid-stimulating monoclonal antibodies","volume":"12","author":"Sanders","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102560","article-title":"The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors","volume":"79","author":"Zhang","year":"2023","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104766_b0370","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1021\/acs.jmedchem.4c01525","article-title":"Targeting thyroid-stimulating hormone receptor: a perspective on small-molecule modulators and their therapeutic potential","volume":"67","author":"Zhang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0375","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/acs.jmedchem.5b00007","article-title":"Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the \u03b4-opioid receptor","volume":"58","author":"Burford","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0395","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1073\/pnas.0904506106","article-title":"Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice","volume":"106","author":"Neumann","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104766_b0400","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/thy.2011.0025","article-title":"Small-molecule thyrotropin receptor agonist activates naturally occurring thyrotropin-insensitive mutants and reveals their distinct cyclic adenosine monophosphate signal persistence","volume":"21","author":"Allen","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/thy.2014.0119","article-title":"New small molecule agonists to the thyrotropin receptor","volume":"25","author":"Latif","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117258","article-title":"Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist","volume":"84","author":"Karstens","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0415","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1089\/thy.2022.0694","article-title":"Thyrotropin receptor antagonism by a novel small molecule: preclinical in vitro observations","volume":"33","author":"Kahaly","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2026.104766_b0420","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/j.1476-5381.2011.01709.x","article-title":"Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor","volume":"165","author":"van Koppen","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104766_b0425","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1210\/jc.2011-2931","article-title":"Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist","volume":"97","author":"van Zeijl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.drudis.2026.104766_b0430","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1210\/en.2010-0199","article-title":"A small molecule inverse agonist for the human thyroid-stimulating hormone receptor","volume":"151","author":"Neumann","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0435","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1210\/en.2008-0836","article-title":"A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism","volume":"149","author":"Neumann","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2026.104766_b0440","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/thy.2018.0349","article-title":"A new highly thyrotropin receptor-selective small-molecule antagonist with potential for the treatment of Graves\u2019 orbitopathy","volume":"29","author":"Marcinkowski","year":"2019","journal-title":"Thyroid"},{"issue":"491","key":"10.1016\/j.drudis.2026.104766_b0445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1134\/S1607672920020064","article-title":"New thieno-[2,3-d]pyrimidine-based functional antagonist for the receptor of thyroid stimulating hormone","volume":"2020","author":"Derkach","year":"2020","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.drudis.2026.104766_b0450","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fendo.2020.00372","article-title":"A Gq biased small molecule active at the TSH receptor","volume":"11","author":"Latif","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.drudis.2026.104766_b0455","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1074\/jbc.C600014200","article-title":"A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone\/chorionic gonadotropin receptor (LHCGR)","volume":"281","author":"J\u00e4schke","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0460","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1134\/S1607672922020016","article-title":"Development of low-molecular-weight allosteric agonist of thyroid-stimulating hormone receptor with thyroidogenic activity","volume":"503","author":"Bakhtyukov","year":"2022","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.drudis.2026.104766_b0465","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/fmc-2021-0292","article-title":"Dual-targetinhibitors based on PARP1: new trend in the development of anticancer research","volume":"14","author":"Ge","year":"2022","journal-title":"Future Med Chem"},{"key":"10.1016\/j.drudis.2026.104766_b0470","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104766_b0485","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials","volume":"9","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.drudis.2026.104766_b0490","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1061186X.2016.1236112","article-title":"Recent advances in targeting mTOR signaling pathway using small molecule inhibitors","volume":"25","author":"Roohi","year":"2017","journal-title":"J Drug Target"},{"key":"10.1016\/j.drudis.2026.104766_b0495","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"TSH Ligand-based CAR-T cell effectively eradicates TSHR-positive thyroid cancer with favorable safety profile","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2026.104766_b0500","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1562662","article-title":"Chimeric autoantibody receptor T cells specifically eliminate Graves\u2019 disease autoreactive B cells","volume":"16","author":"Cheever","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104766_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110873","article-title":"TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease","volume":"124","author":"Duan","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.drudis.2026.104766_b0510","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10792-025-03535-0","article-title":"Thyroid-related orbitopathy: clinical overview, novel medical treatments and the role of orbital surgery","volume":"45","author":"Giannuzzi","year":"2025","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.drudis.2026.104766_b0515","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells14120936","article-title":"Spatial transcriptomics in thyroid cancer: applications, limitations, and future perspectives","volume":"14","author":"Song","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104766_b0520","article-title":"Thyroid-stimulating hormone receptor mediates peripheral-central neuroimmune crosstalk in autoimmune thyroid diseases","volume":"2026","author":"Zhang","year":"2026","journal-title":"BMC Med"},{"key":"10.1016\/j.drudis.2026.104766_b0525","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1021\/acs.jproteome.8b00515","article-title":"Current technologies for complex glycoproteomics and their applications to biology\/disease-driven glycoproteomics","volume":"17","author":"Narimatsu","year":"2018","journal-title":"J Proteome Res"},{"key":"10.1016\/j.drudis.2026.104766_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.177835","article-title":"Potential impact of organophosphate esters on thyroid eye disease based on machine learning and molecular docking","volume":"957","author":"Jia","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.drudis.2026.104766_b0535","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12902-023-01360-z","article-title":"Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.drudis.2026.104766_b0540","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0078","article-title":"The evolving therapeutic landscape of Graves' disease in adults: present and future","volume":"14","author":"Stan","year":"2025","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.drudis.2026.104766_b0545","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1326823","article-title":"B cell receptor repertoire abnormalities in autoimmune disease","volume":"15","author":"Yuuki","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104766_b0550","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells14141102","article-title":"Pathogenesis of Graves\u2019 disease determined using single-cell sequencing with thyroid autoantigen peptide stimulation in B cells","volume":"14","author":"Kobayashi","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104766_b0555","article-title":"Application of immune repertoire analysis in differentiating thyroid cancer and large benign thyroid nodules","volume":"9","author":"Zhu","year":"2025","journal-title":"Adv Biol (Weinh)"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:18:11Z","timestamp":1790093891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626001716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1359644626001716"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104766","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From structural biology to precision medicine\u2014decoding the key receptor in thyroid disorders","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104766"}}